PROMUS PREMIER™ China Post-Approval Study
NCT03273023
·
clinicaltrials.gov ↗
COMPLETED
Status
2059
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DEVICE:
Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System
Sponsor
Boston Scientific Corporation